Immune Therapies for Myeloma, With Drs. Saad Usmani and Nikhil Munshi

In this podcast, Contributing Editor Dr. Saad Usmani has a conversation with Dr. Nikhil Munshi. They discuss Dr. Usmani’s Mini Review article from the July/August 2021 issue of The Hematologist, titled, "Immune Therapies for Myeloma: The CARs Are Here but What’s Next?" They discuss the latest approvals of chimeric antigen receptor T-cell therapies to treat multiple myeloma. You can access his Mini Review article online at Additional ASH affiliation and COI information: Dr. Usmani has received research funding from Amgen, Array Biopharma, BMS, Celgene, GSK, Janssen, Merck, Pharmacyclics, Sanofi, Seattle Genetics, SkylineDX, and Takeda; consulting fees from Amgen, BMS, Celgene, EdoPharma, GSK, Janssen, Sanofi, Seattle Genetics, SecuraBio, SkylineDX, Takeda, and TeneoBio; speaker fees from Amgen, BMS, Janssen, and Sanofi. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

You can listen to Immune Therapies for Myeloma, With Drs. Saad Usmani and Nikhil Munshi online on Radio and Podcast. Open the player on this page to stream the available audio.

Immune Therapies for Myeloma, With Drs. Saad Usmani and Nikhil Munshi is an episode from The Hematologist by The Hematologist.

This episode is 00:20:40 long.

This episode was published on Jul 1, 2021.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from The Hematologist when more episodes are available from the podcast feed.